Lilly’s weekly insulin succeeds in late-stage studies

(Reuters) – Eli Lilly said on Thursday that its once-weekly insulin efsitora met the main goals in two late-stage trials evaluating it in people with type 2 diabetes.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)